Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy

Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy

Purpose To compare the efficacy and safety of intravitreal aflibercept (IVA) monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) (IVA+RF-PDT) for the treatment of polypoidal choroidal vasculopathy (PCV).Methods and analysis Multicentred, double-masked, randomis...

Full description

Bibliographic Details
Main Authors: Tien Yin Wong, Kelvin Yi Chong Teo, Anna Tan, Chinmayi Himanshuroy Vyas, Colin Tan, Caroline Chee, Kelly Wong, Janice Marie N. Jordan-Yu, Beau Fenner, Shaun Sim
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/7/e050252.full

Internet

https://bmjopen.bmj.com/content/11/7/e050252.full

Similar Items